National Institute of Chemistry, Ljubljana, Slovenia.
J Mol Model. 2012 May;18(5):1735-53. doi: 10.1007/s00894-011-1179-0. Epub 2011 Aug 12.
The virtual combinatorial chemistry approach as a methodology for generating chemical libraries of structurally-similar analogs in a virtual environment was employed for building a general mixed virtual combinatorial library with a total of 53.871 6-FQ structural analogs, introducing the real synthetic pathways of three well known 6-FQ inhibitors. The druggability properties of the generated combinatorial 6-FQs were assessed using an in-house developed drug-likeness filter integrating the Lipinski/Veber rule-sets. The compounds recognized as drug-like were used as an external set for prediction of the biological activity values using a neural-networks (NN) model based on an experimentally-determined set of active 6-FQs. Furthermore, a subset of compounds was extracted from the pool of drug-like 6-FQs, with predicted biological activity, and subsequently used in virtual screening (VS) campaign combining pharmacophore modeling and molecular docking studies. This complex scheme, a powerful combination of chemometric and molecular modeling approaches provided novel QSAR guidelines that could aid in the further lead development of 6-FQs agents.
采用虚拟组合化学方法作为在虚拟环境中生成结构相似类似物的化学文库的方法,构建了一个包含总共 53871 个 6-FQ 结构类似物的通用混合虚拟组合文库,引入了三种已知 6-FQ 抑制剂的真实合成途径。使用内部开发的药物相似性过滤器,集成了 Lipinski/Veber 规则集,评估了生成的组合 6-FQ 的可药性特性。将被识别为具有药物样性质的化合物用作基于实验确定的一组活性 6-FQ 的神经网络 (NN) 模型预测生物活性值的外部集。此外,从具有预测生物活性的药物样 6-FQ 池中提取了一组化合物,随后在结合药效团建模和分子对接研究的虚拟筛选 (VS) 活动中使用。这种复杂的方案是化学计量学和分子建模方法的强大组合,提供了新的 QSAR 指导方针,可帮助进一步开发 6-FQ 药物先导化合物。